Persistent Herpes Simplex Virus Infections Established in Two Burkitt Lymphoma Derived Cell Lines

Size: px
Start display at page:

Download "Persistent Herpes Simplex Virus Infections Established in Two Burkitt Lymphoma Derived Cell Lines"

Transcription

1 J. gen. ViroL 0976), 32, Printed in Great Britain 51 Persistent Herpes Simplex Virus Infections Established in Two Burkitt Lymphoma Derived Cell Lines By W. G. ROBEY, B. J. GRAHAM, C. L. HARRIS,* M. J. MADDEN, G. R. PEARSON-~ AND G. F. VANDE WOUDE Viral Biology Branch, National Cancer Institute, Bethesda, Maryland 2ooi4, U.S.A. (Accepted 3 March I976 ) SUMMARY Examination of P3HR-I cells (Epstein-Barr virus [EBV] producer) persistently infected with the MAL strain of herpes simplex virus type I (HSV-I) suggested that only a few cells were actively producing a virus indistinguishable from HSV- ~ (MAL) despite the presence of immunofluorescent HSV-~ antigens associated with the majority of cells. EBV-specific immunottuorescence was not altered in HSV-I persistently infected P3HR-I cells. HSV-~ persistently infected cells, labelled for 72 h with 14C-thymidine, incorporated approx. 8 % of the label into cell associated HSV-I DNA as resolved by caesium chloride gradients. Values greater than 8 % of the total were suggested by hybridization of gradient fractions with 3H-HSV- I DNA. To determine whether the establishment of HSV persistent infections in Burkitt lymphoma derived cells was a general phenomenon, six strains of HSV-I (MAL, KOS, Patton, Syn R, BF and Syn V) and two strains of type 2 (333 and MS) were used to infect the P3HR-I and Raji (EBV non-producer) cell lines derived from Burkitt lymphomas. In P3HR-I cells, persistent infections were established with all strains of HSV-~ but not with HSV-2. In Raji cells, persistent infections were established with all strains of HSV-I, except Syn V, and with both strains of HSV-2. No external support was required to maintain these infections. INTRODUCTION Studies performed by Henle, Henle & zur Hausen 0969) and Floyd et al. 097 I) with several Burkitt lymphoma (BL) derived cell lines containing Epstein-Barr virus (EBV) demonstrated marked differences in their permissiveness to infection by herpes simplex viruses type I (HSV-t) and type 2 (HSV-2). In such infected cells, virus replication varied from a typical cytopathic effect (c.p.e.) within I day after infection to a delayed cell death requiring as long as 7 weeks. In order to extend these studies further, particularly with respect to the variations in permissiveness of BL derived cell lines to herpesvirus replication, we infected the EBV producing clone, P3HR-I, of Jijoye (or P3J) cells (Hinuma & Grace, I967) and the non-producing Raji cells (Pulvertaft, I965) with six strains of HSV-I and two strains of HSV-2. We subsequently observed that persistent infections could be established with most virus strains in both cell types and the maintenance of these persistent infections required no external support. An extensive characterization of P3HR-I cells persistently infected with the MAL strain of HSV-~ suggested an atypical HSV-I replication. * Present address: Frederick Cancer Research Center, Frederick, Maryland. -~ Present address: Mayo Clinic, Rochester, Minnesota.

2 5 2 W. G. ROBEY AND OTHERS METHODS Cell cultures. P3HR-I and Raji cells were grown and maintained in RPMI ~64o medium supplemented with IO ~ heat-inactivated foetal calf serum (FCS), glutamine (2 ram), penicillin (o'o5 mg/ml) and streptomycin (o'o5 mg/ml) in a humidified 5 ~ carbon dioxide atmosphere at 37 C. Vero cells (American Type Culture Collection, CCL 8 t) were grown and maintained in the same medium supplemented with Hepes buffer (25 ram). Grand Island Biological Company (Grand Island, N.Y.) media and supplements were used throughout. P3HR-I cells were subcultured every I2 to t4 days and Raji cells every 6 to 8 days by diluting 2 Io viable cells (trypan blue exclusion) to 2o ml with medium and incubating as described. Cultures were routinely tested for mycoplasma by broth and agar methods (Microbiological Associates, Bethesda, Md.) and were found to be negative. Electron microscopic analyses for mycoplasma, as well as detection of mycoplasma DNA on caesium chloride gradients, were also negative. Virus. The MAL strain of HSV-I, cloned 3 times in Vero cells, was obtained from Dr Berge Hampar (National Cancer Institute, Bethesda, Md.). Two syncytial variants of the MAL strain were isolated in this laboratory by serial passage of this virus through Vero (Syn V) or through JLSV9 mouse cells producing Rauscher leukaemia virus (Syn R; Andrese et al. unpublished data). The KOS strain of HSV-I was obtained from Dr John J. Docherty (The Pennsylvania State University, University Park, Pa.). A fresh oral isolate of HSV (BF) was obtained from Dr Bernhard Fleckenstein (der Universitat Erlangen-Nurnberg, Erlangen, Germany) and determined to be HSV-I by neutralization kinetics. The Patton strain of HSV-T and 333 strain of HSV-z were obtained from Electronucleonics, Inc. (Silver Spring, Md.). The MS strain of HSV-z was obtained from Dr Alan Rabson (National Cancer Institute, Bethesda, Md.). Stocks of the above laboratory strains of herpesviruses, except the BF strain, were produced after multiple passages through Vero cells. A stock of the BF strain was obtained by two passages through Veto cells. Virus assay. Virus was added to freshly confluent Vero monolayers in a volume of o.a ml, incubated for 15 rain at 25 C followed by 45 min at 37 C and then re-fed with 4 ml of Vero maintenance medium (4 ~ FCS). The cultures were incubated 30 to 36 h at 37 C before staining with 0"5 ~ crystal violet in 7o ~o methanol. Virus titres are expressed as p.f.u.]ml. Herpesvirus infection. Two million viable cells from I2 to 14 day P3HR-~ or 6 to 8 day Raji cultures were collected by centrifuging at 80o g for 5 min and resuspended in a ml of growth medium containing the appropriate amount of virus for high and low multiplicities of infection (m.o.i.). Sham-infected control cells were resuspended in medium. The cultures were incubated for z h at 37 C in a shaker bath, transferred to 75 cm 2 plastic flasks (Falcon Plastics, Oxnard, Ca.), diluted to Io ml with medium and incubated at 37 C. Infected P3HR-I cultures were maintained through the initial infection and two routine passages of ~4 days each and infected Raji cultures were maintained through the initial infection and two routine passages of 7 days each. Samples of the above culture fluids and cells were diluted with complete medium, frozen at -70 C until titration, thawed, filtered through o-45 #m Swinnex filters (Millipore Corporation, Bedford, Ma.) and titred on Vero monolayers. Adsorption of HSV-I (MAL). Vero and P3HR-I cell suspensions were prepared and treated in a manner similar to that described by Docherty, Mantyjarvi & Rapp (I972) except diluted and centrifuged portions were filtered through o'45/zm Swinnex filters and stored at -70 C until titred on Vero cell monolayers. Titres are presented as unadsorbed virus in p.f.u./ml.

3 Persistent HSV infections in lymphoma cells 53 Infectious centre assay. Two million viable P3HR-I cells were infected for 2 h at 37 C in a shaker bath with HSV- I(MAL) at a m.o.i, of I-o and o.oi p.f.u./cell, washed 3 times with complete medium and adjusted to a concentration such that 0-2 ml contained either 5 Io2 (m.o.i. = I.o p.f.u./cell) or 5 x io ~ (m.o.i. = o-oi p.f.u./cell) viable cells. Replicate monolayers of Vero cells were infected at these multiplicities. After incubation for 2 h at 37 C, cells were removed by trypsinization, washed 3 times with complete medium and adjusted so o.2 ml contained either I x Io z or 5 x io ~ (m.o.i. = I.o p.f.u./cell) or I x Io ~ (m.o.i. = o'oi p.f.u./cell) viable cells. The appropriate number of infected P3HR-I or Vero cells in o-2 ml were plated on to Vero monolayers in 6o mm diam. Petri dishes (Falcon Plastics), incubated I5 min at 25 C, 45 min at 37 C and then very carefully overlayered with 4 ml of complete medium containing o'5 ~ (w/v) methyl cellulose. The plates were then incubated in a 5 ~ CO2 humidified atmosphere at 37 C. Immunofluorescence. Washed cell smears were prepared on slides, dried at 37 C, fixed in acetone for Io rain and treated for 45 min at 37 C with the appropriately diluted human serum that was either positive for EBV (virus capsid antigen and early antigen) and negative for HSV or positive for HSV and negative for EBV. Smears were washed with saline and reacted with goat anti-human IgG (heavy and light chain) conjugated with ftuorescein isothiocyanate (Hyland Laboratories, Costa Mesa, Ca.) and examined by ultraviolet microscopy. Isotopic labelling and purification of cellular and HSV DNA. Approx. 2 Io 8 Veto cells were infected with HSV-I(MAL) at a m.o.i, of Io and incubated at 37 C. Cells were labelled with io #Ci/ml of 3H-thymidine (6 Ci/mmol, New England Nuclear, Boston, Ma.) beginning 3 h post infection (p.i.) until 9o ~ c.p.e. (8 to Io h) was observed. The P3HR-I control and HSV-I infected cultures at a density of I Io 6 viable cells/ml were labelled with I/zCi/ml of 14C-thymidine (40 mci/mmol, New England Nuclear) for 72 h. The collected cell pellet from P3HR-I cells was suspended in Io vol. of phosphate-buffered saline (PBS), lysed with I ~o SDS and incubated for 8 h at 37 C with autodigested pronase (Calbiochem, San Diego, Ca.) at a final concentration of 2oo #g/ml. The DNA was deproteinized by two phenol extractions followed by two extractions with chloroform-isoamyl alcohol (96:4). The methods of virus purification, viral DNA isolation and isopycnic centrifugation of DNA were the same as those described by Simonds et al. (I975). Radioactivity was determined as trichloroacetic acid insoluble ct/min using a Packard model 338o liquid scintillation counter. DNA-DNA filter hybridization. The techniques of filter hybridization used (Gillespie & Spiegelman, 1965; Denhardt, I966; Warnaar & Cohen, I966)" contained the following modifications. Cell DNA was denatured with o-2 N-NaOH for 30 rain at room temperature. The salt concentration of the DNA solution was increased to 3 SSC (SSC = Ioo mm- NaC1, Io mm-sodium citrate) and the DNA was immobilized on to pre-soaked (3 x SSC) nitrocellulose membrane filters (Schleicher and Schuell, Keene, N.H.) and washed once with neutralizing solution (I.O M-tris-HC1, ph 7"5, 0.6 M-NaC1) and once with 3 x SSC. After drying for 8 h at 8o C, the filters were incubated for 5 h at 66 C in 5 ml of preincubation medium (Denhardt, 1966 ). 3H-HSV-I DNA (5 x io 5 ct/min//~g) was sheared by sonication (six I min intervals), heat denatured (3o min at IO5 C) and quickly chilled on ice. Three x IO ct/min of DNA in I.o ml of 3 x SSC was added to each filter. The hybridization reaction was terminated after incubation at 66 C for 22 to 24 h. The filters were washed three times with 3 x SSC on both sides and radioactivity was determined as described above.

4 54 W. G. ROBEY AND OTHERS 6-5 I I I 1! i 6-0 ~.. ~ i ~ 5"5-,s 45 "~, '/' /" N ~g/ 4.0 I I i I,, i I I (b) 7'0 o m ~mm\m/m 5.0 ~A A~A~A 2.0,\._/ 3.0 l.o i I i I I i I l Time p.i. (days) Fig. I. (a) Growth and (b) virus production kinetics of P3HR-~ cells infected with HSV-~(MAL) during the infection passage. (a) 0--0, viable control cells; (3..., trypan-blue-sensitive control cells; [], viable cells at m.o.i, of Io; []... ~, trypan-blue-sensitive cells at m.o.i. of Io;, viable cells at m.o.i, of o'ooi; A... A, trypan-blue-sensitive cells at m.o.i, of o-ooi. (b) [] [], virus titre (p.f.u./ml) at m.o.i, of lo; A A, virus titre at m.o.i, of o.ool RESULTS Cell growth and virus produetion kinetics of P3HR-I cells infected with HSV-I The kinetics of HSV-I(MAL) replication in P3HR-I cells was determined at two m.o.i. When the rate of P3HR-~ cell growth at the higher 0o) and lower (o.ooi) m.o.i, were compared to sham-infected controls, only the culture infected at the higher m.o.i, showed a growth lag between 5 and 9 days p.i. (Fig. I a) perhaps indicating slight HSV-induced c.p.e. However, by I I days after infection the three cultures were equivalent in cell growth. The virus production curve (Fig. I b) for both HSV-~ infected cultures showed a distinct 3-day lag before new virus was produced. This lag was markedly different from that observed following a similar HSV-I m.o.i, on Veto cells where maximum virus production occurred within t2 to 4 8 h after infection and resulted in total c.p.e. (data not shown). The time of maximum virus production preceded maximum cell growth by 2 days in the low m.o.i, and

5 Persistent HSV infections in lymphoma cells t I I t i.6 E.E >- f/3 lo s \ 10 4 I I I I Time p.i. (rain) Fig. 2. Adsorption of HSV-x(MAL) by P3HR-I (0 O) and Vero (O... ) cells at m.o.i, of (a) I.o and (b) 0'I. Titres represent HSV-I remaining in solution. by 6 days in the high m.o.i, which indicated that virus production appeared to be related to m.o.i, and, more importantly, to the rate of cell growth. Since a typical HSV-I c.p.e, was not observed in these cultures, the HSV-I infected cells were passaged and examined for continued HSV-I production. After the first passage, no differences were detected between the growth rates and number of viable or trypan-bluesensitive cells in the control and the two HSV infected P3HR-I cultures; further, infected cultures were indistinguishable with respect to the rate and level of HSV production (data not shown) and, in effect, had become persistently infected. P3HR-I cells infected with HSV-I(MAL) in an analogous manner have now undergone 44 routine passages without losing the ability to produce HSV-I. I 120 Kinetics of HSV-I adsorption to P3HR-I and Vero cells To determine whether the establishment of a persistent infection in P3HR-I cells and not Vero cells was related to differing virus adsorption characteristics, the kinetics of HSV-I adsorption were compared using both cell types (Fig. 2). At the m.o.i, tested, Vero cells adsorbed HSV-I at a rate greater than P3HR-I cells during the first I5 rain but the extent of adsorption for both cell types was the same after 2 h. Both cell types adsorbed approx. 7o ~ of the input p.f.u. More than 9o % of the input virus was recovered in the virus controls after z h. Infectious centre assay of infected P3HR-I and infected Vero cells Since the extent of adsorption of HSV-I to P3HR-~ and Vero cells was shown to be equivalent, an infectious centre assay was used to determine the number of each cell type that became productively infected (Table I). At both m.o.i., infected Vero cells produced plaques within 48 h and total c.p.e, by 72 h whereas infected P3HR-I cells did not produce any plaques prior to 7z h and then only < 1% of the cells plated were productively infected. Immunofluorescence of HSV- I superinf ected P3HR- t cells To determine the extent of HSV antigenic expression as a function of passage level, a P3HR-I culture persistently infected with HSV-I(MAL) was examined by indirect

6 56 W. G. ROBEY AND OTHERS Table I. Infectious centre assay of HSV-I(MAL) infected Vero and P3HR-I cells HSV-I infected cells Plaques* plated on to Vero HSV c - - ~ ' monolayers m.o.i. 48 h 72 h 90 h I IO ~ Vero I'O 62 c.p.e.t -- 5 x io s Vero I-o 236 c.p.e x Io 2 P3HR-I I'O o 3 45 I x IO 4 Vero o'oi I93 c.p.e X IO n` P3HR.-I o'oi o 2 35 * Average of 4 plates. t Total c.p.e. J; Microscopically visible secondary plaques detected. Table 2. Immunofluorescence of HSV-I(MAL) in infected and control P3HR-I cells Immunofluorescence (% of positive cells) y, P3HR-I culture EBV HSV Control (all passages) io o Infected passage 3 IO 3o Infected passage 6 I o 8o Infected passage 24 IO 80 immunoftuorescence (Table 2). The percentage of cells showing HSV-specific fluorescence increased from 3o % at passage 3 to 8o % by passage 6. After 24 routine passages, no further changes were observed in the percentage of cells positive for HSV. In cells from the same culture, HSV infection had no effect on EBV expression since Io % of the cells were constantly positive for EBV antigens. Similar results were obtained by Zajac, Henle & Henle (1969) and Henle et al. (I969). The effect of multiple medium changes on virus production in HSV-I persistently infected P3HR-I cells" The effect of multiple medium changes on a HSV-I(MAL) persistently infected P3HR-I culture (passage level 6) was studied to determine whether c.p.e, could be induced by continuous cell growth (Henle et al. I969) or ifa cyclical relationship existed between cell growth and virus production (Hampar & Copeland, I965). Cell culture fluids were harvested, replaced with fresh medium at 3- to 4-day intervals and cell counts and virus titres were determined (Fig. 3)- Under these conditions, the HSV-I infected ceils continued to grow and produced an average of 5 los p.f.u./ml. At times when high HSV titres were obtained (day 16, I9 and 4I) no significant variations in the numbers of viable and trypan-blue-sensitive cells were observed. Furthermore, throughout the experiment, the percentage of cells showing HSV and EBV-specific fluorescence remained constant at 80 % and IO % respectively. Thus, after 48 days of continuous cell growth, no evidence for increased cell death was obtained nor did the production of HSV by these cells appear to be cyclical in a manner analogous to the Chinese hamster system studied by Hampar & Copeland (I965). Characterization of virus DNA produced by HSF-I persistently infected P3HR-I cells The DNA of HSV-I produced by persistently infected P3HR-I cells was compared to DNA of the parental HSV-I(MAL) produced in Vero cells to determine whether the two DNA species had related densities in caesium chloride. Extracellular virions were purified

7 Persistent HSV infections in lymphoma cells I,, I I,, I/,~,, ~lr~ 6-5 '~O"" ~...o/ ~ 6-0 / t / /,o, o ~j/o 5.0 # o" I/ 4.5 l I I i I i I i i i i i 7.0 ii-i / ~o- ". an- m/ \=~,,, nn-nn'nn/ \.=~'>- 6.0 (b) l I i i i i i i I I '~ n--i t Time (days) Fig. 3. Effect of multiple medium changes on (a) growth rate and (b) virus production of P3HR-T cells persistently infected with HSV-I(MAL):, viable cells; (3... O, trypan-bluesensitive cells; n, virus titre of cell-free medium (p.f.u./ml). and virus DNA from HSV-T persistently infected and control P3HR-I cultures and HSV-I(MAL) infected Vero cultures were prepared as described (Simonds et al I975). Virions from the HSV-r infected P3HR-I culture contained one major species of DNA which had a buoyant density of I"727 g/rnl which co-banded with DNA isolated from HSV-T(MAL) infected Vero cells and one minor species which had a density of ~'7oo g/ml (Fig. 4)- Pre-treatment of virus with deoxyribonuclease before extraction eliminated the lighter density cellular DNA species while 90 % of the g/ml peak was resistant to digestion (data not shown). EBV DNA in the density region of g/ml (Schulte- Holthausen & zur Hausen, ~97o) was not detected in either the control or HSV-I infected P3HR-~ cultures as the labelling conditions used here were not optimal for EBV production (Hinuma et al. ~967). Thus, HSV-I persistently infected P3HR-I cells produced a virus DNA physically indistinguishable from the parental HSV-I (MAL). Detection of viral DNA in HSV-I persistently infected P3HR-T cells The relative amount of HSV-T DNA synthesized in persistently infected P3HR-t cells was determined by DNA-DNA filter hybridization (Fig. 5). Cellular DNA from HSV-I infected cells, fractionated by isopycnic banding in caesium chloride, contained a minor peak (fractions 36 to 47) of high guanine + cytosine virus DNA which represented approx. 4 % of the total 14C-thymidine incorporated and a major peak of cell DNA (fractions 6o to 80) of high adenine + thymidine content (Fig. 5 a). A more accurate estimate of the amount of high-density DNA labelled, after adjusting for the differential uptake of x~c-thymidine into molecules with different base content (e.g. minor peak = 68 % G + C; cellular peak =

8 58 w. G. ROBEY AND OTHERS 18- I I I l 1 HSV-I i X e-, 12.=_? O 3o 4O 50 Fraction number Fig. 4. Caesium chloride gradient characterization of DNA from extracellular virions purified from HSV-[ persistently infected (Q 0) and control ( (3) P3HR-I cultures. The arrow designates the fraction at which the peak of radioactivity of 8H-labelled HSV-I virion DNA from Vero cells was detected when mixed with 14C-labelled HS -I virion DNA isolated from HSV-I persistently infected P3HR- I cells. 39 ~ G+C), would be 8 ~. When representative gradient fractions were hybridized to 3H-thymidine labelled HSV-I DNA, significant amounts of ~H label were detected in the density region where HSV-I DNA banded and in a region of the gradient more dense than the median density of cell DNA. However, the relative amount of SH bound with respect to the amount of 14C-DNA immobilized on the filter was greater in the high density HSV-I virus DNA region (Fig. 5a). Fractionated control P3HR-I cell DNA bound only small amounts of HSV-I DNA and then only in the low-density cell DNA region (Fig. 5b). Thus, both density species of DNA present in the persistently infected P3HR-I cells contained sequences homologous to virus DNA; and therefore a minimum of 8 ~ of the label incorporated in 72 h was taken to be virus-specific. The response of P3HR-I and Raft cells to infection with two types and several strains of HSV Six strains of HSV-I and two strains of HSV-2 were used to infect P3HR-I and Raji cells at a high and a low m.o.i, to see if other persistent infections could be established. These m.o.i, produced > 80 ~ c.p.e, in Vero cells with all virus strains tested within I2 to 48 h p.i. Differences in response to HSV infection were observed with the P3HR-I and Raji cells as demonstrated by cell growth patterns and virus production (Table 3). Only infected cultures with normal growth rates and those that produced > I x io 2 p.f.u./ml by the end of passage 2 were defined as persistently infected. Some cultures exhibited decreased relative growth

9 Persistent HSV infections in lymphoma cells 59 I I I I I I 3 (a)?, " ", / l \ 1 7 X X e-, 4 (b) 4 ~Z S'/ 0 _ ~ ~o..,...~ t~," I Fraction number Fig. 5. Filter hybridization of HSV-I DNA produced in Vero cells (O... O) with cellular DNA (Q Q) isolated from HSV-I (a) persistently infected and (b) control P3HR-I ceils after caesium chloride density-gradient purification. rates during the infection and/or the first passage (Table 3). The MS strain of HSV-2 at the high m.o.i, was lethal to P3HR-I cells and the Syn V strain of HSV-I was lethal to Raji ceils at both m.o.i. Thus, the surviving cultures were either persistently infected (2o of 3 2 cultures tested) or resistant to infection since virus was not detected after two routine passages. DISCUSSION We observed that persistent infections were established when P3HR-~ cells were infected with the MAL strain of HSV-I instead of the typical herpesvirus replication expected. The characteristics of this particular infection indicated that HSV-I(MAL) adsorbed equally well to P3HR-I cells and to lethally permissive Vero cells but less than 1% of the P3HR-t cells became productively infected compared to the majority of Veto cells. Also, the parent HSV-I(MAL) replicated more slowly in P3HR-I cells than in Veto cells, but the progeny

10 - (o) 60 W.G. ROBEY AND OTHERS Table 3. HSV infection of P3HR-I and Raft cells Growth rate* t Virus Strain m.o.i. Infection Passage i Passage z Log10 titre'~ - HSV-I MAL io.o -- (-) o (o) o (o) 5"8 (6'4) o.ooi o (o) o (o) o (o) 5'9 (5"0) KOS io.o o (-) o (o) o (o) 4"4 (6"3) o.ooi o (o) o (o) o (o) 4"7 (6-7) Patton 2o'o -- (o) o (o) o (o) 5"4 (4"3) 0"o0I o (o) o (o) < 2"0 (5'7) Syn R 0'5 o (o) o (-) o (o) 5"9 (5"5) O'OOI 0 (13) 0 (--) 0 (0) <2"0 (5"5) BF o-i6 o (-) o (-) o (o) 5'5 (6-0) O'OOI O (0) 0 (13) 0 (0) <2"0 (<2"0) SynV IO-O -- (-) o (-) 0 ( ) 6-o (<2.o) O'OOI 0(O) O(--) O(><) <2"0(<2'0) HSV t'3 -- (-) o (o) o (o) <2.o (6'5) 0"002 o (o) o (o) o (o) < 2"o (3"3) MS IO'O o (-) o (-) x(o) <2"o (4'3) o(o) o(o) o(o) <2.0(<2.0) * Growth rates relative to sham-infected controls; P3HR-I cell data presented first and Raji data in parentheses. (o), control rate; (-), decreased rate, > 5o ~ below control; ( ), death. t Virus titre at the end of passage z. At this time, P3HR.-I cell counts ranged from 2"4 IO 6 to 4"2 ~o viable cells/ml and Raji cell counts ranged from z'i IO 6 to 3'5 x [o viable cells/ml. virus from each cell type replicated at the same rate in Vero cells. The majority of persistently infected P3HR-I cells were positive for immunofluorescent HSV antigens by the sixth passage and have remained at equivalent levels through 24 passages. The cells positive for EBV-specific antigens by immunofluorescence remained constant in agreement with other similar observations (Henle et al. ~969; Zajac et al. 1969, Floyd et al. I97 0. To date the HSV-I persistently infected P3HR-I cells have undergone 44 routine passages without losing the ability to produce HSV and as such this infection did not appear to be self-limiting (Blackmore & Morgan, I967). We were unable to significantly accelerate virus production or cell death with multiple medium changes nor did we detect cyclical fluctuations in cell growth and virus production (Hampar, I966). The analyses of radioisotopical!y labelled virus and cellular DNA indicated that the HSV-I persistently infected culture produced a virus DNA physically and genetically related to the parental HSV-t(MAL). A minimum of 8 ~ of the total label incorporated by infected cells in 72 h appeared to be virus DNA. The relative percentage was actually somewhat greater as the cellular DNA fraction also contained HSV DNA sequences as determined by hybridization. Furthermore, when the cellular DNA fraction was recycled on caesium chloride, additional high density virus DNA was detected (data not shown). Analogous observations have been described for EBV DNA associated with Raji cell DNA (Tanaka & Nonoyama, ~974; Adams & Lindahl, I975). For the P3HR-I culture persistently infected with HSV-L we conclude that only about I ~ of the cells are actively producing a virus that is indistinguishable from HSV-I by nucleic acid density and hybridization, although a majority of cells are positive for HSV-~ immunofluorescent antigens. Together with the isotopic DNA studies, these data suggest that the P3HR-I cell exerts control over the replication of HSV-~ which may be analogous

11 Persistent HSV infections in lymphoma cells to the control exerted over the expression of EBV (Hinuma & Grace, 1967; Maurer, Imamura & Wilbert, I97o). The establishment of persistent HSV infections in Burkitt lymphoma derived cells is in contrast to other reports (Henle et al. I969; Floyd et al. 197I). However, it should be noted that although the cells and viruses studied herein were similar to, they were not identical to, those studied by the above investigators. Under the conditions reported here, no external support was required to maintain these infections. To our knowledge, only the HSV-1 persistently infected Chinese hamster cells described and characterized by Hampar & Copeland (I965), Hampar (I966) and Hampar & Burroughs (1969) and the Earle's L cells described by Nii (1969)fit this classification. Persistent HSV-1 infections in cell culture have usually required external support such as the presence of antiserum to HSV (Wheeler & Canby, ~959; Fernandez, 196o; Wheeler, I96o; Hinze & Walker, 196I; Szanto, 1963) decreased (Coleman & Jawetz, 1962 ) or increased (Floyd et al incubation temperatures or co-infection with polyoma virus (Glasgow & Habel, I963). The production of interferon did not appear to be a factor in establishing the persistent infections reported here since virus-free concentrates of tissue culture medium from infected and control P3HR-I cells did not reduce either the rate of appearance or number of vesicular stomatitis virus plaques detected on human foreskin cells (Dr Maneth Gravell, personal communication). Moreover, Henle et al. (1969) were unable to detect interferon in Jijoye and Raji cells following infection with the H strain of HSV-I. Furthermore, since we have been unable to detect mycoplasmas in our cultures, we assumed that this contamination was not a contributing factor in the establishment of persistent infections. We are not suggesting that the observations reported herein for P3HR-I cells persistently infected with HSV-I(MAL) necessarily apply to the other cells and viruses studied (Table 3) since P3HR-I and Raji cells responded to HSV infection in various ways: 0) the cultures were resistant to infection (9 of 32 cultures tested); (2) the cultures were lethally permissive to infection (3 of 32 cultures tested); or the cultures became persistently infected (2o of 32 cultures tested). Whether the resistance to infection is at the adsorption level or due to a true cellular block is under investigation. The establishment of persistent infections was related to the initial virus m.o.i., as some cultures infected at the higher m.o.i, became persistently infected but the same cultures at the lower m.o.i, did not. However, in cultures where persistent infections were established [similar to HSV-I(MAL) in P3HR-I cells], the virus titres at the end of the second passage for the individual cell type were generally equivalent and independent of the initial m.o.i. In all persistent infections established, maximum virus titres were obtained slightly before or at the same time maximum cell population levels were obtained indicating virus replication in these cultures may be dependent on cell growth. Taken together, the variety of responses observed to HSV infection by the two cell lines suggests the presence of complicated interactions involving cell type, virus type and virus strain. We wish to thank Dr Robert Manaker, Dr Richard Ascione, Dr Robert Goldberg, Dr Angelo Andresse and Dr Berge Hampar for their helpful discussions. We thank Dr Maneth Gravell for performing the interferon analyses and the assistance of Mr Tom Orr in the immunofluorescence studies is greatly appreciated. 6I 5 VIR 32

12 62 W. G. ROBEY AND OTHERS REFERENCES ADAMS, A. & LINDAHL, T. (I975). Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proceedings of the National Academy of Sciences of the United States of America 72, I477- I48I. RLACKMORE, a. V. & MORGAN, H. g. (I967). Self-limiting infection with herpes simplex virus in cell culture. Acta Virologiea (Praha) H, COLEUAN, V. & JAWETZ, E. (I96I). A persistent herpes simplex infection in antibody-free cell culture. Virology I3, DENnARDT, O. T. (I 966). A membrane-filter technique for the detection of complementary DNA. Biochemical and Biophysical Research Communications 23, 64 t-646. DOCHERTY, J. J., MANTYJARVI, R. A. & RAPP, F. 0972). Mechanism of the restricted growth of herpes simplex virus type 2 in a hamster cell line. JournalofGeneral Virology x6, FERNANDEZ, C. G. (I960). Persistence of herpes simplex virus in HeLa cells. Nature, London I85, 268. FLOYD~ R., GLASSER, R., VONKA, V. & BENYESit-MELNICK, M. (1971)- Studies on the growth of herpes simplex virus in lymphoblastoid cells. Acta Virologica (Praha) I5, I33-I42. GILL~SPIE, D. & SPIEGELMAN, S. (1965)- A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane. Journal of Molecular Biology I2, ~LASGOW, r. A. & HABEL, K. 0963). Role of polyoma virus and interferon in a herpes simplex virus infection in vitro. Virology x9, HAMPAR, R. (I966). Persistent cyclic herpes simplex virus infections in vitro. III. Asynchrony in the progression of infection and cell regrowth. Journal of Bacteriology 9t, 1965-I97o. HAMPAR, B. & BURROUGHS, M. a. K. 0969)- Mechanism of persistent herpes simplex virus infection in vitro. Journal of the National Cancer Institute 43, HAMPAR, B. & COPELAND, M. g. 0965). Persistent herpes simplex virus infection in vitro with cycles of cell destruction and regrowth. Journal of Bacteriology 9 o, 2o I-IENLE, W., HENLE, G. & ZUR HAUSEN, H. (I969). Effect of herpes simplex virus on cultured Burkitt tumor cells and its failure to influence the Epstein-Barr virus carrier state. Cancer Research 29, IJINUMA, V. & GRACE, J. T. JOY. (1967). Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures. Proceedings of the Society for Experimental Biology and Medicine I24, IO7-III. HINUMA, Y., KONN, M., VAMAGUCHI, J. & GRACE, J. W. JUN. 0967)- Replication of herpes-type virus in a Burkitt lymphoma cell line. Journal of Virology i, I2o3-~2e6. HINZE, H. & WALKER, D. L Variation of herpes simplex virus in persistently infected tissue cultures. Journal of Bacteriology 82, NAORER, ~. A., IMAMURA, L & WlLBERT, S.M. 0970)- Incidence of Epstein-Barr virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines. Cancer Research 3o, 287o NIl, S. (I969) Persistent infection with herpes simplex virus in vitro. I. Establishment and characteristics of persistent herpes simplex virus infection in Earle's L cells. Biken's Journal I2, PULVERTAFT, g. S. V. 0965). A study of malignant tumours in Nigeria by short-term tissue culture. Journal of Clinical Pathology i8, 26~-273. SCHULTE-ROLTHAUSEN, n. & ZUR HAUSEN, H. 097O). Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology 4 o, SIMONDS, J. A., ROBEY, W. G., GRAHAM, B. J., OIE, H. & VANDE WOL1DE, G. F. 0975). Purification of herpesvirus saimiri and properties of the viral DNA. Archives of Virology 49, SZANTO, s. 0963). Course of persistent inflections of HeLa and Detroit 6 cells with herpes simplex virus. Acta Virologica (Praha) I, TANAKA, A. & NONOYAMA, M. 0974). Latent DNA of Epstein-Barr virus: separation from high-molecularweight cell DNA in a neutral glycerol gradient. Proceedings of the National Academy of Sciences of the United States of America 7I, t. WAR~AAR, S. O. & COnE~, J. A. 0966). A quantitative assay for DNA-DNA hybrids using membrane filters. Biochemical and Biophysical Research Communications 24, WHEELER, C.E. 0960). Further studies on the effect of neutralizing antibody upon the course of herpes simplex infections in tissue culture. Journal of Immunology 84, WHEELER, C. E. & eanby, C. M. 0959)- Influence of specific antibody on herpes simplex infections in tissue culture. American Medical Association Archives of Dermatology 79, ZAJAC, B. A., I-IENLE, W. & HENLE, G. (1969). The effect of mumps virus on the resistance of Burkitt lymphoma cell lines to various viruses. Cancer Research 29, ~ 467-~ 475. (Received 27 October I975)

The Spontaneous and Induced Synthesis of Epstein-Barr Virus Antigens in Raji Cells Immobilized on Surfaces Coated with Anti-lymphocyte Globulin

The Spontaneous and Induced Synthesis of Epstein-Barr Virus Antigens in Raji Cells Immobilized on Surfaces Coated with Anti-lymphocyte Globulin J. gen. ViroL (1981), 54, 397-401 397 Printed in Great Britain The Spontaneous and nduced Synthesis of Epstein-Barr Virus Antigens in Raji Cells mmobilized on Surfaces Coated with Anti-lymphocyte Globulin

More information

The Herpes Simplex Virus Type 2 Alkaline DNase Activity Is Essential for Replication and Growth

The Herpes Simplex Virus Type 2 Alkaline DNase Activity Is Essential for Replication and Growth J. gen. Virol. (1986), 67, 1173-1178. Printed in Great Britain 1173 Key words: HSV-2/DNase activity/dna synthesis~growth The Herpes Simplex Virus Type 2 Alkaline DNase Activity Is Essential for Replication

More information

[GANN, 62, ; April, 1971]

[GANN, 62, ; April, 1971] [GANN, 62, 139-143; April, 1971] UDC 576.8.097.3:547.854 EVALUATION OF CELL DAMAGE IN IMMUNE REACTIONS BY RELEASE OF RADIOACTIVITY FROM 3H-URIDINE LABELED For quantitative evaluation of cell damage in

More information

Temperature-Sensitive Cell Mutations that Inhibit Adenovirus 2 Replication

Temperature-Sensitive Cell Mutations that Inhibit Adenovirus 2 Replication Proc. Nat. Acad. Sci. USA Vol. 72, No. 1, pp. 328-332, January 1975 Temperature-Sensitive Cell Mutations that Inhibit Adenovirus 2 Replication (ts BHK cell line/host functions and viral growth) TAKEHARU

More information

ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM

ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM J. Cell Sci. 7, 711-718(1970) 7II Printed in Great Britain ELECTRON-MICROSCOPIC OBSERVATIONS OF POLYOMA VIRUS-TRANSFORMED MOUSE CELLS TREATED WITH SPECIFIC IMMUNE SERUM G.NEGRONI AND RITA TILLY Department

More information

Ultracentrifugal Inoculation

Ultracentrifugal Inoculation INFECTION AND IMMUNITY, Oct. 1980, p. 193-197 0019-9567/80/10-0193/05$02.00/0 Vol. 30, No. 1 Mechanisms of Herpes Simplex Virus Infectivity Enhanced by Ultracentrifugal Inoculation RICHARD B. TENSER* AND

More information

Equilibrium Density Gradient Studies on Simian Virus 40-Yielding Variants of the Adenovirus

Equilibrium Density Gradient Studies on Simian Virus 40-Yielding Variants of the Adenovirus JOURNAL OF VIROLOGY, Apr. 197, p. 421-426 Copyright 197 American Society for Microbiology Vol. 5, No. 4 Printed in U.S.A. Equilibrium Density Gradient Studies on Simian Virus 4-Yielding Variants of the

More information

Cultural Characteristics of a Cell Line Derived

Cultural Characteristics of a Cell Line Derived APPLIED MICROBIOLOGY, Nov. 1972, p. 727-731 Copyright 1972 American Society for Microbiology Vol. 24, No. 5 Printed in U.S.A. Cultural Characteristics of a Cell Line Derived from an Equine Sarcoid R. E.

More information

Virus-specific RNA: Suspension cultures of KB cells at 2-3 X 106 cells/ml were infected

Virus-specific RNA: Suspension cultures of KB cells at 2-3 X 106 cells/ml were infected A METHOD FOR DETERMINING THE FRACTION OF THE VIRAL GENOME TRANSCRIBED DURING INFECTION AND ITS APPLICATION TO ADENOVIRUS-INFECTED CELLS* BY KEI FUJINAGA, STANLEY MAK4 AND MAURICE GREENt INSTITUTE FOR MOLECULAR

More information

7y-globulin) were obtained from Hyland Laboratories, Los Angeles, California. Prior to use, all sera NEUTRALIZATION OF AN INFECTIOUS HERPES SIMPLEX

7y-globulin) were obtained from Hyland Laboratories, Los Angeles, California. Prior to use, all sera NEUTRALIZATION OF AN INFECTIOUS HERPES SIMPLEX NEUTRALIZATION OF AN INFECTIOUS HERPES SIMPLEX VIRUS-ANTIBODY COMPLEX BY ANTI-7t-GLOBULIN BY WARREN K. ASHE AND ABNER Louis NOTKINS LABORATORY OF MICROBIOLOGY, NATIONAL INSTITUTE OF DENTAL RESEARCH, NATIONAL

More information

Inhibition of Herpesvirus hominis Replication by Human Interferon

Inhibition of Herpesvirus hominis Replication by Human Interferon INFECTION AND IMMUNITY, July 1975, p. 104-108 Copyright 0 1975 American Society for Microbiology Vol. 12, No. 1 Printed in U.S.A. Inhibition of Herpesvirus hominis Replication by Human Interferon LUCY

More information

Exercise 23-C BACTERIOPHAGE REPRODUCTION AND PLAQUE FORMATION

Exercise 23-C BACTERIOPHAGE REPRODUCTION AND PLAQUE FORMATION Exercise 23-C BACTERIOPHAGE REPRODUCTION AND PLAQUE FORMATION Introduction The reproductive cycle of a cytolytic bacteriophage called T2 begins with its adsorption onto a sensitive host cell. The phage

More information

Foot-and-Mouth Disease Virus: Selection by

Foot-and-Mouth Disease Virus: Selection by INFECTION AND IMMUNITY, Jan. 1972, p. 65-69 Copyright 1972 American Society for Microbiology Foot-and-Mouth Disease Virus: Selection by Homogenized Calf Kidney Adsorption and Cell Culture Passage Vol.

More information

Dr: RAWIA BADR Associate Professor of Microbiology&Immunology

Dr: RAWIA BADR Associate Professor of Microbiology&Immunology Dr: RAWIA BADR Associate Professor of Microbiology&Immunology Cell culture Commonly refers to the culture of animal cells and tissues, while the more specific term plant tissue.culture is used only for

More information

ab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis

ab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis ab139418 Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis Instructions for Use To determine cell cycle status in tissue culture cell lines by measuring DNA content using a flow cytometer. This

More information

ab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis

ab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis ab139418 Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis Instructions for Use To determine cell cycle status in tissue culture cell lines by measuring DNA content using a flow cytometer. This

More information

VZV Replication Assays Samantha J. Griffiths * and Jürgen Haas

VZV Replication Assays Samantha J. Griffiths * and Jürgen Haas VZV Replication Assays Samantha J. Griffiths * and Jürgen Haas Division of Pathway and Infection Medicine, University of Edinburgh, Edinburgh, UK *For correspondence: samantha.griffiths@ed.ac.uk [Abstract]

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Culture of the Human Monocyte-Macrophage Cell Line; U937 SOP number: WP1/002 Protocol prepared by: Ewelina Hoffman & Abhinav Kumar Developed under NC3R project: NC/C013203/1

More information

Replication of Vesicular Stomatitis Virus Facilitated by Shope

Replication of Vesicular Stomatitis Virus Facilitated by Shope INFECTION AND IMMUNITY, July 1979, p. 213-219 0019-9567/79/07-0213/07 $02.00/0 Vol. 25, No. 1 Replication of Vesicular Stomatitis Virus Facilitated by Shope Fibroma Virus In Vivo NORMAN A. CROUCHt* AND

More information

TECHNICAL BULLETIN NUCLEI EZ PREP NUCLEI ISOLATION KIT. Product Number NUC-101 Store at 2-8 C

TECHNICAL BULLETIN NUCLEI EZ PREP NUCLEI ISOLATION KIT. Product Number NUC-101 Store at 2-8 C NUCLEI EZ PREP NUCLEI ISOLATION KIT Product Number NUC-101 Store at 2-8 C TECHNICAL BULLETIN Product Description Sigma s Nuclei EZ Prep Kit is designed for the rapid isolation of nuclei from mammalian

More information

Human Tenocyte Care Manual

Human Tenocyte Care Manual Human Tenocyte Care Manual INSTRUCTION MANUAL SHIPPING CONDITIONS Human Tenocytes ZBM0075.03 Orders are delivered via Federal Express courier. Cryopreserved cells are shipped on dry ice and should be stored

More information

Mag4C-Ad Kit - Results

Mag4C-Ad Kit - Results Mag4C-Ad Kit - Results Mag4C-Ad Kit Magnetic capture for viral concentration & storage buffer for superior viral preservation OZ Biosciences is delighted to announce the launching of a new product Mag4C-Ad

More information

Human Dermal Fibroblast Manual

Human Dermal Fibroblast Manual Human Dermal Fibroblast Manual INSTRUCTIONAL MANUAL ZBM0023.04 SHIPPING CONDITIONS Human Adult or Neonatal Dermal Fibroblast Cells Orders are delivered via Federal Express courier. All US and Canada orders

More information

Plasmids & Transposable Elements. Dr. Wiaam Ahmed Al-Amili

Plasmids & Transposable Elements. Dr. Wiaam Ahmed Al-Amili Plasmids & Transposable Elements BY Dr. Wiaam Ahmed Al-Amili Plasmid DNA preparation In order to use a vector for cloning, sequencing, etc., it is necessary to isolate the vector in a highly purified form.

More information

Ready to use: Serum free culture in Insectomed SF express

Ready to use: Serum free culture in Insectomed SF express Ready to use: Serum free culture in Insectomed SF express Information from Biochrom AG, 19.05.2010 Serum free culture in Insectomed SF express is a proprietary formulation which has successfully been used

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Culture of the Rat Macrophage Cell Line, NR8383 SOP number: WP1/001 Protocol prepared by: Ewelina Hoffman Developed under NC3R project: NC/C013203/1 INTRODUCTION Procedure

More information

Secretory Immunoglobulin A and Herpes Keratitis

Secretory Immunoglobulin A and Herpes Keratitis INFECTION AND IMMuNrnr, Dec. 1970, p. 778-782 Copyright 1970 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A Secretory Immunoglobulin A and Herpes Keratitis Y. M. CENTIFANTO AND H. E.

More information

The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication

The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication J.gen. ViroL (I98o) 49, 427-43I Printed in Great Britain 427 The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication (Accepted 26 February J98o) SUMMARY Both herpes simplex virus type

More information

The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication

The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication J.gen. ViroL (I98o) 49, 427-43I Printed in Great Britain 427 The Effect of A-9-Tetrahydrocannabinol on Herpes Simplex Virus Replication (Accepted 26 February J98o) SUMMARY Both herpes simplex virus type

More information

Mag4C-Lv Kit - Results

Mag4C-Lv Kit - Results Mag4C-Lv Kit - Results Mag4C-Lv Kit Magnetic capture for viral concentration & storage buffer for superior viral preservation OZ Biosciences is delighted to announce the launching of a new product Mag4C-Lv

More information

The Surface Nature of Proteins of a Bovine Enterovirus, Before and After Neutralization

The Surface Nature of Proteins of a Bovine Enterovirus, Before and After Neutralization J. gen. ViroL (976), 32, 17-23 Printed in Great Britain 17 The Surface Nature of Proteins of a Bovine Enterovirus, Before and After Neutralization By P. CARTHEW* Department of Biochemistry, Queen's University

More information

Deoxyribonucleoside Triphosphate Pools in Cells Infected with Deoxypyrimidine Kinaseless Herpes Simplex Virus

Deoxyribonucleoside Triphosphate Pools in Cells Infected with Deoxypyrimidine Kinaseless Herpes Simplex Virus J. gen. ViroL (1976), 3 x, I~5-I23 Printed in Great Britain II5 Deoxyribonucleoside Triphosphate Pools in Cells Infected with Deoxypyrimidine Kinaseless Herpes Simplex Virus By A. T. JAMIESON* AND G. BJURSELL

More information

Ni-NTA Agarose. User Manual. 320 Harbor Way South San Francisco, CA Phone: 1 (888) MCLAB-88 Fax: 1 (650)

Ni-NTA Agarose. User Manual. 320 Harbor Way South San Francisco, CA Phone: 1 (888) MCLAB-88 Fax: 1 (650) Ni-NTA Agarose User Manual 320 Harbor Way South San Francisco, CA 94080 Phone: 1 (888) MCLAB-88 Fax: 1 (650) 871-8796 www. Contents Introduction -----------------------------------------------------------------------

More information

Purification of cytoplasmic RNA from animal cells using the RNeasy Mini Kit

Purification of cytoplasmic RNA from animal cells using the RNeasy Mini Kit QIAGEN Supplementary Protocol: Purification of cytoplasmic RNA from animal cells using the RNeasy Mini Kit This protocol requires the RNeasy Mini Kit. IMPORTANT: Please consult the Safety Information and

More information

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536 Data Sheet TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536 Product Description Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7

More information

ProductInformation. Genomic DNA Isolation Kit. Product No. GDI-3 Technical Bulletin No. MB-275 May 2000 TECHNICAL BULLETIN

ProductInformation. Genomic DNA Isolation Kit. Product No. GDI-3 Technical Bulletin No. MB-275 May 2000 TECHNICAL BULLETIN Genomic DNA Isolation Kit Product No. GDI-3 Technical Bulletin No. MB-275 May 2000 TECHNICAL BULLETIN ProductInformation Product Description Sigma s Genomic DNA Isolation Kit isolates genomic DNA from

More information

Human Skeletal Muscle Myoblast Care Manual: Maintenance and Differentiation from Myoblasts to Myocytes

Human Skeletal Muscle Myoblast Care Manual: Maintenance and Differentiation from Myoblasts to Myocytes Human Skeletal Muscle Myoblast Care Manual: Maintenance and Differentiation from Myoblasts to Myocytes STORAGE CONDITIONS Media: Short Term 4 C 6 months -20 C F or research use only. Not approved for human

More information

Persistent Herpes Simplex Virus Infection In Vitro with Cycles of Cell Destruction and Regrowth

Persistent Herpes Simplex Virus Infection In Vitro with Cycles of Cell Destruction and Regrowth JOURNAL OF 13ACTERIOLOGY, JUly, 1965 Copyright 1965 Amiierican Society for!microbiology Vol. 90, No. 1 Printed in U.S. A. Persistent Herpes Simplex Virus Infection In Vitro with Cycles of Cell Destruction

More information

Adenovirus Types 2 and 12

Adenovirus Types 2 and 12 JOURNAL OF VIROLOGY, Feb. 1970, p. 188-193 Copyright @ 1970 American Society for Microbiology Functional Heterogeneity of Virions in Human Adenovirus Types 2 and 12 ANDREW J. RAINBOW AND STANLEY MAK Biology

More information

Overview of Current Molecular Biology Techniques

Overview of Current Molecular Biology Techniques Overview of Current Molecular Biology Techniques VRSP Journal Club June 5, 2017 Chester McDowell Outline DNA preparation and analysis RNA preparation and analysis RNA-Protein Complexes Proteins Cell Culture

More information

High throughput screening: Huh-7 cells were seeded into 96-well plate (2000

High throughput screening: Huh-7 cells were seeded into 96-well plate (2000 1 SUPPLEMENTARY INFORMATION METHODS 6 7 8 9 1 11 1 1 1 1 16 17 18 19 High throughput screening: Huh-7 cells were seeded into 96-well plate ( cells/well) and infected with MOI of DENV-. One hour post-infection

More information

1. Cross-linking and cell harvesting

1. Cross-linking and cell harvesting ChIP is a powerful tool that allows the specific matching of proteins or histone modifications to regions of the genome. Chromatin is isolated and antibodies to the antigen of interest are used to determine

More information

EZ-DNA. Instructions for Use. Genomic DNA Isolation Reagent. Product Description. Kit Reagent. Reagent Required But Not Supplied.

EZ-DNA. Instructions for Use. Genomic DNA Isolation Reagent. Product Description. Kit Reagent. Reagent Required But Not Supplied. EZ-DNA Genomic DNA Isolation Reagent Cat. No.: 20-600-50 Store at: Room Temperature Instructions for Use Protocol for Genomic DNA Isolation Tissue Specific Recommendations for the Use of EZ-DNA Assessing

More information

TECHNICAL BULLETIN. Goat ExtrAvidin Peroxidase Staining Kit. Product Number EXTRA-1 Storage Temperature 2-8 C

TECHNICAL BULLETIN. Goat ExtrAvidin Peroxidase Staining Kit. Product Number EXTRA-1 Storage Temperature 2-8 C Goat ExtrAvidin Peroxidase Staining Kit Product Number EXTRA-1 Storage Temperature 2-8 C TECHNICAL BULLETIN Product Description The unique avidin reagent, ExtrAvidin, combines the high specific activity

More information

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot)

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Masheal Aljumaah SEP 2018 Learning Objectives: What is blotting? Blotting Techniques Types. Applications for each technique.

More information

Pre-made expression Adenovirus product manual

Pre-made expression Adenovirus product manual Pre-made expression Adenovirus product manual Catalog# Product Name Amounts AVP001 RFP adenovirus AVP002 AVP004 AVP005 AVP011 AVP012 AVP017 AVP010 AVP013 AVP014 AVP015 AVP016 AVP-Null AVP001-PBS AVP002-PBS

More information

ICH CONSIDERATIONS Oncolytic Viruses

ICH CONSIDERATIONS Oncolytic Viruses European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ICH CONSIDERATIONS Oncolytic Viruses 20 November 2008 EMEA/CHMP/GTWP/607698/2008

More information

DNA Isolation Reagent for Genomic DNA

DNA Isolation Reagent for Genomic DNA DNA Isolation Reagent for Genomic DNA Phenol-free solution for rapid isolation of genomic DNA Product-No. A3418 Description DNA Isolation Reagent for Genomic DNA is a non-organic and ready-to-use reagent

More information

ICH Considerations. Oncolytic Viruses September 17, 2009

ICH Considerations. Oncolytic Viruses September 17, 2009 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses

More information

Rab5 Activation Assay Kit

Rab5 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Rab5 Activation Assay Kit Catalog Number: 83701 20 assays 24 Whitewoods Lane 1 Table of Content Product

More information

Removal of RNase activity from DNase by affinity chromatography on agarosecoupled aminophenylphosphoryl-uridine-2'(3')-phosphate

Removal of RNase activity from DNase by affinity chromatography on agarosecoupled aminophenylphosphoryl-uridine-2'(3')-phosphate . 1 January 1977 Nucleic Acids Research Removal of RNase activity from DNase by affinity chromatography on agarosecoupled aminophenylphosphoryl-uridine-2'(3')-phosphate Ian H.Maxwell, Francoise Maxwell

More information

JOURNAL OF VIROLOGY, Mar. 2000, p Vol. 74, No. 5. Copyright 2000, American Society for Microbiology. All Rights Reserved.

JOURNAL OF VIROLOGY, Mar. 2000, p Vol. 74, No. 5. Copyright 2000, American Society for Microbiology. All Rights Reserved. JOURNAL OF VIROLOGY, Mar. 2000, p. 2107 2120 Vol. 74, No. 5 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Roscovitine, a Specific Inhibitor of Cellular Cyclin-Dependent

More information

SANTA CRUZ BIOTECHNOLOGY, INC.

SANTA CRUZ BIOTECHNOLOGY, INC. TECHNICAL SERVICE GUIDE: Western Blotting 2. What size bands were expected and what size bands were detected? 3. Was the blot blank or was a dark background or non-specific bands seen? 4. Did this same

More information

Arf6 Activation Assay Kit

Arf6 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Arf6 Activation Assay Kit Catalog Number: 82401 20 assays NewEast Biosciences 1 Table of Content Product

More information

Epstein-Barr Virus Genomes with Properties of Circular DNA Molecules in Carrier Cells (virus latency/herpesviruses/raji cells)

Epstein-Barr Virus Genomes with Properties of Circular DNA Molecules in Carrier Cells (virus latency/herpesviruses/raji cells) Proc. Nat. Acad. Sci. USA Vol. 72, No. 4, pp. 1477-1481, April 1975 pstein-barr Virus Genomes with Properties of Circular DNA Molecules in Carrier Cells (virus latency/herpesviruses/raji cells) ALIC ADAMS

More information

TransIT -Lenti Transfection Reagent

TransIT -Lenti Transfection Reagent Quick Reference Protocol, SDS and Certificate of Analysis available at mirusbio.com/6600 INTRODUCTION Lentivirus is an enveloped, single-stranded RNA virus from the Retroviridae family capable of infecting

More information

OPPF-UK Standard Protocols: Mammalian Expression

OPPF-UK Standard Protocols: Mammalian Expression OPPF-UK Standard Protocols: Mammalian Expression Joanne Nettleship joanne@strubi.ox.ac.uk Table of Contents 1. Materials... 3 2. Cell Maintenance... 4 3. 24-Well Transient Expression Screen... 5 4. DNA

More information

Vivapure AdenoPACK 20

Vivapure AdenoPACK 20 Technical data and operating instructions. For in vitro use only. Vivapure AdenoPACK 20 Adenovirus (Ad5) purification and concentration kit for up to 20 ml cell culture volume (E.g. 1+15 cm plate) 85030-523-69

More information

IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only

IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only Introduction The IgG TrueBlot for mouse, rabbit, or goat-derived antibodies represents unique series of respective

More information

Immunohistochemistry guide

Immunohistochemistry guide Immunohistochemistry guide overview immunohistochemistry Overview Immunohistochemistry is a laboratory technique utilized for the visual detection of antigens in tissue. When working with cells this technique

More information

CARE MANUAL INSTRUCTIONAL MANUAL ZBM SHIPPING CONDITIONS STORAGE CONDITIONS ORDERING INFORMATION AND TECHNICAL SERVICES

CARE MANUAL INSTRUCTIONAL MANUAL ZBM SHIPPING CONDITIONS STORAGE CONDITIONS ORDERING INFORMATION AND TECHNICAL SERVICES HUMAN ADULT DERMAL FIBROBLAST CARE MANUAL INSTRUCTIONAL MANUAL ZBM0023.01 SHIPPING CONDITIONS Human Adult Dermal Fibroblast Cells Orders are delivered via Federal Express courier. All US and Canada orders

More information

Fitness Measurements of Evolved Escherichia coli Migla Miskinyte and Isabel Gordo *

Fitness Measurements of Evolved Escherichia coli Migla Miskinyte and Isabel Gordo * Fitness Measurements of Evolved Escherichia coli Migla Miskinyte and Isabel Gordo * Evolutionary Biology Group, Instituto Gulbenkian de Ciência, Oeiras, Portugal *For correspondence: igordo@igc.gulbenkian.pt

More information

Human Adult Mammary Fibroblast Care Manual

Human Adult Mammary Fibroblast Care Manual Human Adult Mammary Fibroblast Care Manual INSTRUCTIONAL MANUAL ZBM0062.05 SHIPPING CONDITIONS Human Adult Mammary Fibroblast Cells Orders are delivered via Federal Express courier. All US and Canada orders

More information

1. Add 0.4 ml Phenol:Chloroform:Isoamyl alcohol and gently rotate tubes 3-4 hours at room temp. 2. Spin max. speed in microcentrifuge for 5 minutes.

1. Add 0.4 ml Phenol:Chloroform:Isoamyl alcohol and gently rotate tubes 3-4 hours at room temp. 2. Spin max. speed in microcentrifuge for 5 minutes. High MW Genomic DNA Isolation Lysis Buffer: 100 mm NaCl 10 mm Tris ph 8.0 25 mm EDTA ph 8.0 0.5% SDS Lyse cells Tissue: Cut frozen tissues into small pieces with a razor blade, and grind into powder with

More information

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS A PREPARATIVE METHOD FOR OBTAINING ENUCLEATED MAMMALIAN CELLS Michael H. Wigler and I. Bernard Weinstein Institute of Cancer Research and Departments of Medicine and Microbiology, College of Physicians

More information

Data Sheet PD-1 / NFAT - Reporter - Jurkat Recombinant Cell Line Catalog #: 60535

Data Sheet PD-1 / NFAT - Reporter - Jurkat Recombinant Cell Line Catalog #: 60535 Data Sheet PD-1 / NFAT - Reporter - Jurkat Recombinant Cell Line Catalog #: 60535 Product Description Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements

More information

RESISTANCE TO LYSIS FROM WITHOUT IN BACTERIA INFECTED WITH T2 BACTERIOPHAGE'

RESISTANCE TO LYSIS FROM WITHOUT IN BACTERIA INFECTED WITH T2 BACTERIOPHAGE' RESISTANCE TO LYSIS FROM WITHOUT IN BACTERIA INFECTED WITH T2 BACTERIOPHAGE' N. VISCONTI Department of Genetics, Carnegie Institution of Washington, Cold Spring Harbor, New York Received for publication

More information

Gα 13 Activation Assay Kit

Gα 13 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Gα 13 Activation Assay Kit Catalog Number: 80401 20 assays NewEast Biosciences 1 Table of Content Product

More information

RNA Blue REAGENT FOR RAPID ISOLATION OF PURE AND INTACT RNA (Cat. No. R011, R012, R013)

RNA Blue REAGENT FOR RAPID ISOLATION OF PURE AND INTACT RNA (Cat. No. R011, R012, R013) RNA Blue REAGENT FOR RAPID ISOLATION OF PURE AND INTACT RNA (Cat. No. R011, R012, R013) WARNING: RNA Blue contains phenol and some other toxic components. After contact with skin, wash immediately with

More information

DNA isolation from tissue DNA isolation from eukaryotic cells (max. 5 x 106 cells) DNA isolation from paraffin embedded tissue

DNA isolation from tissue DNA isolation from eukaryotic cells (max. 5 x 106 cells) DNA isolation from paraffin embedded tissue INDEX KIT COMPONENTS 3 STORAGE AND STABILITY 3 BINDING CAPACITY 3 INTRODUCTION 3 IMPORTANT NOTES 4 EUROGOLD TISSUE DNA MINI KIT PROTOCOLS 5 A. DNA isolation from tissue 5 B. DNA isolation from eukaryotic

More information

Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW)

Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW) Propagation of H7 hesc From: UW (John Stamatoyannopoulos) ENCODE group Date: 12/17/2009 Prepared By: S. Paige/S. Hansen (UW) Growth and Harvest Modifications Addendum to: Propagation of H7 hesc from UW

More information

Diagnosis and Quantification of Strawberry Vein Banding Virus Using Molecular Approaches

Diagnosis and Quantification of Strawberry Vein Banding Virus Using Molecular Approaches Diagnosis and Quantification of Strawberry Vein Banding Virus Using Molecular Approaches Ali Mahmoudpour Department of Plant Pathology, University of California, Davis, CA, 95616, USA Current Address:

More information

Replication of Rous Sarcoma Virus in Synchronized Cells

Replication of Rous Sarcoma Virus in Synchronized Cells 3. gen. ViroL 0970), 7, 85-93 Printed in Great Britain 85 Replication of Rous Sarcoma Virus in Synchronized Cells By BARBARA HOBOM-SCHNEGG, HARRIET L. ROBINSON AND W. S. ROBINSON Department of Medicine,

More information

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing

More information

Clonetics Skeletal Muscle Myoblast Cell Systems HSMM Instructions for Use

Clonetics Skeletal Muscle Myoblast Cell Systems HSMM Instructions for Use Lonza Walkersville, Inc. Walkersville, MD 21793-0127 USA U.S. Scientific Support: 800 521 0390 scientific.support@lonza.com EU/ROW Scientific Support: +32 87 321 611 scientific.support.eu@lonza.com Document

More information

GenUP Virus DNA/RNA Kit

GenUP Virus DNA/RNA Kit Product Insert GenUP Virus DNA/RNA Kit LOT: See product label EXPIRY DATE: See product label ORDERING INFORMATION PRODUCT GenUP Virus DNA/RNA Kit CAT. NO. BR0701101 BR0701102 BR0701103 SIZE 10 preps 50

More information

Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation

Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation Protocols for Neural Progenitor Cell Expansion and Dopaminergic Neuron Differentiation In vitro neurological research presents many challenges due to the difficulty in establishing high-yield neuronal

More information

Ribonucleic acid (RNA)

Ribonucleic acid (RNA) Ribonucleic acid (RNA) Ribonucleic acid (RNA) is more often found in nature as a singlestrand folded onto itself. Cellular organisms use messenger RNA (mrna) to convey genetic information (using the nitrogenous

More information

Properties of a new phage lytic for Brucella suis

Properties of a new phage lytic for Brucella suis J. gen. Virol. (I973), 2I, 539-544 Printed in Great Britain 539 Properties of a new phage lytic for Brucella suis (Accepted 2I August 1973) SUMMARY The properties of a new brucella phage isolated from

More information

Cdc42 Activation Assay Kit

Cdc42 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Cdc42 Activation Assay Kit Catalog Number: 80701 20 assays 1 Table of Content Product Description 3 Assay

More information

Herpes Simplex Virus Infection of in vitro Cultured Neuronal Cells (Mouse Neuroblastoma C 1300 Cells)

Herpes Simplex Virus Infection of in vitro Cultured Neuronal Cells (Mouse Neuroblastoma C 1300 Cells) J. gen. ViroL (1978), 39, 321-33z Printed in Great Britain 321 Herpes Simplex Virus Infection of in vitro Cultured Neuronal Cells (Mouse Neuroblastoma C 1300 Cells) By ANDERS VAHLNE AND ERIK LYCKE Department

More information

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 European Medicines Agency October 2009 EMEA/CHMP/ICH/607698/2008 ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 TRANSMISSION TO INTERESTED

More information

TR DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.

TR DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited. Chapter 14. Intracellular detection of viral transcription and replication using RNA FISH i. Summary/Abstract Many hemorrhagic fever viruses require BSL-3 or 4 laboratory containment for study. The necessary

More information

Adenovirus-Associated Virus Multiplication

Adenovirus-Associated Virus Multiplication JOURNAL OF VIROLOGY, July 1972, p. 1-8 Copyright 1972 American Society for Microbiology Vol. 10, No. I Printed int U.S.A. Adenovirus-Associated Virus Multiplication VII. Helper Requirement for Viral Deoxyribonucleic

More information

Cells Culture Techniques Marta Czernik

Cells Culture Techniques Marta Czernik Cells Culture Techniques 13.03.2018 Marta Czernik Why we need the cell/tissue culture Research To overcome problems in studying cellular behaviour such as: - confounding effects of the surrounding tissues

More information

Nascent Chromatin Capture. The NCC protocol is designed for SILAC-based massspectrometry

Nascent Chromatin Capture. The NCC protocol is designed for SILAC-based massspectrometry Extended experimental procedure Nascent Chromatin Capture. The NCC protocol is designed for SILAC-based massspectrometry analysis of nascent versus mature chromatin composition (1). It requires a large

More information

Using the xcelligence RTCA SP Instrument to Perform GPCR Assays

Using the xcelligence RTCA SP Instrument to Perform GPCR Assays xcelligence Real-Time Cell Analysis GPCR Assay Protocol Using the xcelligence RTCA SP Instrument to Perform GPCR Assays Overview The xcelligence RTCA SP Instrument The xcelligence Real-Time Cell Analyzer

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure Title Subtitle NANoREG Work package/task: Owner and co-owner(s) HTS Comet Assay with and without FPG - 20 wells Comet assay with and without FPG using Trevigen 20-well slides

More information

RheB Activation Assay Kit

RheB Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based RheB Activation Assay Kit Catalog Number: 81201 20 assays NewEast Biosciences 1 FAX: 610-945-2008 Table

More information

Antibody was principally purchased from Santa Cruz (EGFR sc-03), Cetuximab (Bristol

Antibody was principally purchased from Santa Cruz (EGFR sc-03), Cetuximab (Bristol Materials and Methods Reagents Antibody was principally purchased from Santa Cruz (EGFR sc-03), Cetuximab (Bristol Mayer Squib), IgG (Jacson Laboratory), Carboplatin (Bristol Mayer Squib), Para formaldehyde

More information

ApoTrack Cytochrome c Apoptosis ICC Antibody Kit

ApoTrack Cytochrome c Apoptosis ICC Antibody Kit ab110417 ApoTrack Cytochrome c Apoptosis ICC Antibody Kit Instructions for Use For the Immunocytochemistry analysis of cytochrome c and a mitochondrial marker (Complex Vα) in apoptotic cells and non-apoptotic

More information

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Background Human CD137 (4-1BB; TNFRS9) is an inducible co-stimulatory molecule that activates T cells. CD137:CD137L-mediated

More information

Using the xcelligence RTCA SP Instrument to Perform Cytotoxicity Assays

Using the xcelligence RTCA SP Instrument to Perform Cytotoxicity Assays xcelligence Real-Time Cell Analysis Cytotoxicity Assay Protocol Using the xcelligence RTCA SP Instrument to Perform Cytotoxicity Assays Overview The xcelligence RTCA SP Instrument The xcelligence Real-Time

More information

Protocol Using a Dox-Inducible Polycistronic m4f2a Lentivirus to Reprogram MEFs into ips Cells

Protocol Using a Dox-Inducible Polycistronic m4f2a Lentivirus to Reprogram MEFs into ips Cells STEMGENT Page 1 OVERVIEW The following protocol describes the transduction and reprogramming of one well of Oct4-GFP mouse embryonic fibroblasts (MEF) using the Dox Inducible Reprogramming Polycistronic

More information

JPMA 06, Dec., Case Studies of Established Conditions in Analytical Procedures. Biopharmaceutical Committee Technology Working Committee

JPMA 06, Dec., Case Studies of Established Conditions in Analytical Procedures. Biopharmaceutical Committee Technology Working Committee CMC Strategy Forum Japan 2016 Case Studies of Established Conditions in Analytical Procedures Biopharmaceutical Committee Technology Working Committee JPMA 06, Dec., 2016 Akira Nonoyama Santen Pharmaceutical

More information

Monoclonal antibodies

Monoclonal antibodies Monoclonal antibodies 1. Boost the best-responded mouse 3-5 days before fusion. 2. Build up frozen stock of myeloma cells (NS-1 or P 3 U 1 etc.) in MEM + 10% FCS containing 0.1

More information

Diagnostic Virology. Diagnostic Virology

Diagnostic Virology. Diagnostic Virology Diagnostic Virology Diagnostic Virology The purpose is to diagnose viral diseases in the patient This can be achieved by: Directly detecting the virus or viral products Indirectly detecting an immunological

More information

Adeno Associated Virus (AAV) Purification ViraKit

Adeno Associated Virus (AAV) Purification ViraKit Catalog Number 003061 003063 Adeno Associated Virus (AAV) Purification ViraKit Protocol FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR HUMAN CLINICAL PROCEDURES. Please read through the entire kit

More information

Evolution of Escherichia coli to Macrophage Cell Line Migla Miskinyte and Isabel Gordo *

Evolution of Escherichia coli to Macrophage Cell Line Migla Miskinyte and Isabel Gordo * Evolution of Escherichia coli to Macrophage Cell Line Migla Miskinyte and Isabel Gordo * Evolutionary Biology Group, Instituto Gulbenkian de Ciência, Oeiras, Portugal *For correspondence: igordo@igc.gulbenkian.pt

More information